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Objective(s): This study evaluated short-term and long-term out-
comes for the management of type B thoracic aortic dissection (TAD) and
thoracoabdominal aortic dissection (TAAD) based on initial treatment
modality as well as interval therapy in the Medicare national database.
Methods: The Medicare Beneficiary Database (2005-2008) was used to
identify patients who underwent treatment of type B TADor TAAD. Comorbidi-
ties, 30-day and long-term mortality, therapy conversion, and complications were
recorded. Statistical analysis for categoric variables were compared with 2 and
continuous variables with t test. Propensity score evaluation was performed for
comparison of treatment groups with similar comordities.
Results: Treatment in 10,041 patients was medical in 8413 (84%), open
surgical in 1222 (12%), or thoracic endovascular aneurysm repair (TEVAR) in
406 (4%). Patients who receivedmedical therapy were older than open or TEVAR
patients (76 vs 72 vs 71 years) and had higher rates of cardiac, renal failure, and
hypertension. The 30-day mortality was 23.5% for medical, 21.2% for open, and
11.9% for TEVAR. During the index hospitalization, the open group had signifi-
cantly greater rates of cardiac, renal, bleeding, and pulmonary complications. Initial
medical therapywas converted toTEVARin2.5%andtoopenrepair in2.3%.Open
repair was converted to TEVAR in 0.5% and redo open in 1.0%. TEVAR required
redo TEVAR in 2.7% and open in 1.6%. Long-term survival was improved for
TEVAR and open repair compared with medical therapy (Fig). Propensity score
evaluation revealed significant survival advantage at 1000 days for TEVAR (P 
.0006) and open repair (P .0059) compared with medical therapy.
Conclusions: Patients undergoing TEVAR have a significantly im-
proved short-term survival, and open surgical and TEVAR repair have a
significantly improved long-term survival compared with the medical man-
agement of type B TAD and TAAD. When patient groups with similar
comordities are compared using a propensity score, there is even a greater
advantage for TEVAR and open repair compared with medical manage-
ment. Further evaluation will be required to validate this observation.
Outcomes of Pediatric Blunt Thoracic Aortic Injury
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Objective(s):Outcomesdata onpediatric patientswithblunt thoracic aortic
injury (BTAI) are scarce.Thepurposeofour studywas toassess clinical presentation
and to gauge the effect of BTAI treatment in this cohort during an 18-year period.
Methods: Prospective data of 18 pediatric patients with BTAI were
reviewed, including type of intervention (nonoperative treatment, open
repair, or endovascular therapy), injury severity score (ISS), and early mor-
bidity and mortality.
Results: There were 13 pediatric patients (72%) who sustained BTAI
(median age, 16  3 years). The most common mechanism of trauma was
motor vehicle accident, with the head and thoracic components responsible
for the highest ISS (head, 4  1.2; thorax, 4.6  0.6; mean ISS, 46.2 
15.30). Eight patients (44%) had nonoperative treatment, seven (39%) had
open repair, and three (17%) had endovascular therapy, with similar ISS. A
prolonged hospital length of stay (alive, 24.9  13.9 days vs dead, 49.0 
33.6 days; P .05) and higher ISS (alive, 37.8 10.7 vs dead, 59.6 11.6;
P  .0009) were associated with higher mortality rates. Complications
included acute renal failure in two, access-related complication in one, and
no stroke or paraplegia. The overall mortality of hospitalized patients was
39%; most of the survivors were discharged home.
Conclusions: Mortality remains high in pediatric patients with BTAI.
A higher ISS and more prolonged length of stay were associated with higher
mortality rates. Endovascular therapy may aid treatment of selected young
patients with very high ISS.
Feasibility of Concurrent Thoracic and Abdominal Aortic Endovascu-
lar Repair
Muhammad Asad Khan,MD, Kuldeep Singh, MD, Jonathan Schor, MD,
Jonathan Deitch, MD. Staten Island University Hospital, Staten Island, NY
Objective(s): The aim of this study was to evaluate safety and periop-
erative outcomes in patients undergoing simultaneous thoracic endovascular
aortic repair (TEVAR) and endovascular abdominal aneurysm repair
(EVAR).
Methods: National Surgical Quality Improvement Program (NSQIP)
data were reviewed for patients undergoing elective EVAR and TEVAR
between 2007 and 2009. Simultaneous TEVAR and EVAR procedures were
identified from Current Procedural Terminology (CPT) Codes. Patients
who had concomitant TEVAR-EVAR (group A) were compared with the
TEVAR cohort (group B). Demographic, risk factor, morbidity, and mor-
tality data were examined. Univariate analysis between groups was per-
formed using 2 or t tests.
Results: We identified 8844 procedures, of which 7943 (89.8%) were
isolated EVAR, 842 (9.5%) were isolated TEVAR, and 59 (0.7%) were
TEVAR-EVAR. Demographic data were similar for both cohorts, except
group A had more men (76.3% vs 57.8%, P  .05). Comorbidities were
similar between groups; however, group A had a better American Society of
Anesthesiologists risk profile. Group A required increased operative time and
need for blood transfusion, but this was not statistically significant. Group A
and B had similar unadjustedmajormorbidity (16.9% vs 17.2%, P .99) and
mortality (1.7% vs 4.5%, P  .507). Four patients in group A (6.8%) had
postoperative pneumonia, four (6.8%) required prolonged intubation, two
(3.4%) had acute renal failure, seven (11.9%) required return to the operat-
ing room, and one had (1.7%) neurologic complication, comparable with
isolated TEVAR group.
Conclusions: Our results suggest that a single-stage, simultaneous
EVAR and TEVAR is technically feasible, safe, and might constitute an
attractive alternative to a traditional two-stage procedure.
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